Ultragenyx Pharmaceutical | RARE - Należności Handlowe

Cena Akcji
23.30
Dzienna Zmiana
-0.61 -2.55%
Miesięcznie
4.91%
Rocznie
-31.75%
Q2 Prognozy TE
22.66




Należności Handlowe Zmiana Data
Acadia Pharmaceuticals USD 148.23M 8.79M 2025-12
Agios Pharmaceuticals USD 10.58M 5.55M 2025-12
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
BioCryst Pharmaceuticals USD 106.82M 15.49M 2025-12
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
Esperion Therapeutics USD 140.19M 21.21M 2025-12
Immunic USD 1.5M 50K 2024-06
Insmed USD 140.86M 75.6M 2025-12
Ionis Pharmaceuticals USD 66M 41.39M 2025-12
Karyopharm Therapeutics USD 26.18M 5.6M 2025-12
Kyowa Hakko Kirin JPY 181.2B 29.38B 2025-12
MacroGenics USD 13.37M 55.86M 2025-12
Moderna USD 184M 862M 2025-12
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
PTC Therapeutics USD 181.62M 21.45M 2025-12
Puma Biotechnology USD 28.1M 3.52M 2024-06
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12
Xoma USD 14.78M 4.96M 2024-06